Balaji Amines Share News - Latest Updates, Live News & More

Latest news about Balaji Amines

Balaji Amines Shares Jump 13% on ₹258-Crore Government Subsidy Approval 7 days ago

Balaji Amines stock jumped 13% following Maharashtra government's approval of ₹258-crore subsidy package under mega project investment scheme. The enhanced incentive includes industrial promotion subsidy linked to 50% SGST on eligible products, complete electricity and stamp duty exemptions, valid for seven years from January 2024 to December 2030.

Balaji Amines Promoter Pledges 6.25 Lakh Shares to HDFC Bank for Credit Facilities Jan 02, 2026

Balaji Amines Promoters Pledge 6.25 Lakh Shares to HDFC Bank for Credit Facilities Jan 02, 2026

Balaji Amines Promoter Pledges 3.75 Lakh Shares to HDFC Bank for Credit Facilities Jan 02, 2026

Balaji Amines Summoned to Court for Alleged Drug and Cosmetics Act Violations Nov 24, 2025

More news about Balaji Amines

18Nov 25

Balaji Amines Reports Q2 FY26 Results: EBITDA Margins Improve Amid Revenue Dip

Balaji Amines, a specialty chemicals manufacturer, released Q2 FY26 results. Revenue decreased 4.7% QoQ to ₹341.00 crores, but EBITDA margin improved to 19.00% from 17.00%. Profit After Tax remained steady at ₹37.00 crores. Total volumes were 26,165 metric tons. The company is progressing on projects including a DME Plant, N-Methyl Morpholine Project, and Acetonitrile Expansion. Balaji Specialty Chemicals Limited, a subsidiary, is advancing a ₹750.00 crore expansion plan. Despite challenges, the company maintains optimism about medium to long-term prospects, focusing on new capacities, import substitution, and high-value products.

12Nov 25

Balaji Amines Reports Stable Q2FY26 Performance Amid Market Challenges

Balaji Amines reported Q2FY26 consolidated revenue of ₹341.00 crore, EBITDA of ₹67.00 crore, and net profit of ₹37.10 crore. EBITDA margin improved to 19.00%. Total sales volume was 26,165 MT. The company remains zero-debt on a standalone basis and is progressing with expansion projects including a DME Plant and N-Methyl Morpholine facility. Its subsidiary, Balaji Speciality Chemicals Limited, is undertaking a ₹750.00 crore expansion project. Despite current challenges in pharma and agrichem sectors, the company anticipates gradual improvement in coming quarters as new capacities become operational.

10Nov 25

Balaji Amines Reports Mixed Q2 Results: Profit Dips, EBITDA Margin Improves Slightly

Balaji Amines, a specialty chemicals manufacturer, reported mixed Q2 results. Consolidated net profit decreased to ₹346.00 million from ₹410.00 million year-over-year. Revenue fell to ₹3.40 billion from ₹3.50 billion. However, EBITDA margin slightly improved to 17.56% from 17.49%. The Amines & Speciality Chemicals segment reported revenue of ₹34,106.70 million and profit before interest and tax of ₹5,055.01 million. The Hotel Division generated revenue of ₹724.84 million with a profit before interest and tax of ₹97.61 million. The company's balance sheet shows total assets of ₹233,145.99 million and total equity of ₹205,636.08 million.

06Aug 25

Balaji Amines Maintains Rs 3,000 Crore Revenue Target for FY27 Despite Industry Headwinds

Balaji Amines Ltd (BAL) maintains its FY27 revenue target of Rs 3,000 crore despite a 7% decline in Q1 FY26 consolidated revenue to Rs 367.00 crore. Net profit dropped to Rs 36.53 crore from Rs 46.00 crore in Q1 FY25. Despite revenue decline, BAL saw increased volumes, expecting 10-12% volume growth. The company is pursuing strategic initiatives including anti-dumping protection, new plant commissioning, and expansion projects. BAL is investing in new products and has commissioned a solar power plant to reduce costs. Managing Director D Ram Reddy expressed confidence in achieving growth targets, citing marginal growth in the last quarter and increased volumes in the current quarter.

05Aug 25

Balaji Amines Reports Q1FY26 Results: Revenue Up 2% QoQ, Margins Under Pressure

Balaji Amines reported consolidated revenue of ₹367.00 crore for Q1FY26, a 2% increase from Q4FY25 but a 7% year-on-year decline. Total volumes increased to 27,570 MT. Despite revenue growth, profitability metrics showed pressure with EBITDA at ₹64.00 crore and PAT at ₹37.00 crore, both declining year-on-year. The company continues to progress on expansion projects including a DME plant, NMM facility, and upgraded Acetonitrile plant. Balaji Amines commissioned an 8 MW DC solar power plant in April 2025 for sustainability and cost reduction. The company maintains a zero-debt status on a standalone basis.

02Aug 25

Balaji Amines Reports Q1 FY26 Results with Standalone Profit of Rs 39.80 Crore

Balaji Amines, a leading specialty chemicals manufacturer, announced its Q1 FY26 financial results. Standalone revenue from operations was Rs 319.38 crore, down 4.04% year-over-year. Profit After Tax stood at Rs 39.80 crore, a 1.78% decrease. Consolidated revenue was Rs 358.34 crore with a PAT of Rs 38.00 crore. The Amines & Speciality Chemicals segment generated Rs 316.66 crore in revenue, while the Hotel Division contributed Rs 10.27 crore. Despite slight decreases, the company maintained a strong financial position and profitability.

30Jun 25

Balaji Amines Set to Launch Isopropylamine Production in 2025

Balaji Amines, a specialty chemicals manufacturer, has announced plans to commence commercial production of Isopropylamine on June 30, 2025. This expansion is expected to diversify the company's product portfolio and potentially open new market segments. Isopropylamine is a key chemical compound used in agriculture, pharmaceuticals, and rubber processing industries.

25Jun 25

Balaji Amines Set to Begin Isopropylamine Production Following Approval

Balaji Amines Ltd. has received approval to commence manufacturing of Isopropylamine, a key chemical compound used in pesticides, rubber chemicals, and pharmaceuticals. The company plans to start trial and commercial production soon, potentially expanding its market reach and revenue streams in the specialty chemicals sector. This development is part of Balaji Amines' growth strategy and product diversification efforts.

29May 25

Balaji Amines Reports 15% Revenue Decline in Q4 FY25, Stock Drops 7%

Balaji Amines, a specialty chemicals manufacturer, reported a significant decline in its Q4 FY25 financial results. Revenue fell 15% year-over-year to ₹353.00 crore, EBITDA decreased 39% to ₹59.70 crore, and Profit After Tax (PAT) declined 44% to ₹40.40 crore. The EBITDA margin contracted to 16.90%. For the full fiscal year 2025, PAT decreased by 32% to ₹158.00 crore compared to the previous year. Following the announcement, the company's stock price fell up to 7% in trading.

28May 25

Balaji Amines Reports Q4 Results: Profit Up QoQ, Announces ₹11 Per Share Dividend

Balaji Amines Ltd. has recommended a final dividend of ₹11 per equity share. Q4 financial results show a consolidated net profit of ₹401.00 million, down from ₹680.00 million YoY but up from ₹332.00 million QoQ. Revenue decreased by 14.60% YoY to ₹3.50 billion, while EBITDA fell 38.90% YoY to ₹597.00 million. The EBITDA margin contracted to 16.92% from 23.60% in the previous year. Despite YoY declines, the company shows sequential improvement and maintains a double-digit EBITDA margin.

03Apr 25

Balaji Amines Boosts Sustainability with 6 MW Solar Power Plant

Balaji Amines Limited, a specialty chemicals manufacturer, has commissioned a 6 MW AC solar power plant on April 2, 2025. The plant will be operational in phases under Grid Connectivity, with the generated power used for captive consumption under open access regulations. This move aims to reduce energy costs, enhance sustainability, and improve energy security for the company's operations.